Pharma 2020: From vision to decision

View this page in: Русский, Українська

The pharmaceutical industry is at a critical juncture. The tools to develop remarkable new medicines are materialising, demand for its products is increasing and the barriers to free trade are falling. But pharma also faces major economic and operational challenges, if it’s to capitalise on these opportunities and create more value for healthcare payers, providers and patients. Pharma 2020: From vision to decision outlines how companies can reach 2020 in a position to benefit from more favourable conditions thereafter – and the most important decisions senior management will need to make.